Skip to content

Effect of azelastine fluticasone nasal spray on nasal function and symptoms of moderate to severe allergic rhinitis

Effect of azelastine fluticasone nasal spray on nasal function and symptoms of moderate to severe allergic rhinitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098648
Enrollment
Unknown
Registered
2025-03-12
Start date
2025-03-13
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Nitrostin fluticasone nasal spray group:Azotrostin fluticasone nasal spray
Azotrostin Nasal Spray Group:Nitrostin nasal spray

Sponsors

Peking Union Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adolescents or adults, aged 12-65 years; 2. A history of moderate to severe allergic rhinitis for more than 2 years meets one of the following 4 criteria: (1) Decreased quality of life (2) Affect social functions (3) Affect sleep (4) Affect study/work 3. Allergic rhinitis is confirmed by skin test or allergen specific IgE detection.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating female patients; 2.Allergic to the ingredients of the experimental drug; 3.Nasal ulcer (grade 3), perforation of the nasal septum (grade 4), other nasal diseases or structural abnormalities; 4.Nasal or sinus surgery within 1 year; 5.Uncontrolled asthma with FEV1<75%; 6.Patients with severe lung disease or arrhythmia, glaucoma or cataracts;

Design outcomes

Primary

MeasureTime frame
Symptom score;

Countries

China

Contacts

Public ContactPan Zhouxian

Peking Union Hospital, Chinese Academy of Medical Sciences

panzhouxian@pumch.cn+86 10 69151601

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026